3
(Adds CEO comment in paragraphs 5-6, analysts comment in paragraphs 7,11, details and background throughout) By Kunal Das and Christy Santhosh Sept 25 (Reuters) – The US FDA on Friday approved Mirum
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)